AlphaCrest Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-20,407
Closed -$3.59M 637
2022
Q3
$3.59M Buy
20,407
+14,928
+272% +$3.06M 0.22% 63
2022
Q2
$1.1M Sell
5,479
-4,459
-45% -$951K 0.05% 621
2022
Q1
$2.25M Buy
9,938
+782
+9% +$184K 0.13% 204
2021
Q4
$2.47M Sell
9,156
-5,995
-40% -$1.48M 0.09% 323
2021
Q3
$3.66M Sell
15,151
-2,872
-16% -$724K 0.19% 116
2021
Q2
$4.27M Buy
+18,023
New +$4.11M 0.18% 139
2021
Q1
Sell
-4,606
Closed -$805K 1244
2020
Q4
$805K Buy
4,606
+1,908
+71% +$330K 0.07% 409
2020
Q3
$436K Buy
+2,698
New +$428K 0.05% 660
2020
Q2
Sell
-4,121
Closed -$447K 1018
2020
Q1
$447K Sell
4,121
-11,216
-73% -$1.62M 0.05% 622
2019
Q4
$2.23M Buy
15,337
+288
+2% +$41.6K 0.18% 99
2019
Q3
$2.17M Buy
15,049
+8,661
+136% +$1.26M 0.13% 206
2019
Q2
$949K Buy
6,388
+2,022
+46% +$282K 0.08% 420
2019
Q1
$574K Sell
4,366
-901
-17% -$111K 0.09% 405
2018
Q4
$572K Buy
+5,267
New +$706K 0.17% 197

Other funds holding LH

AlphaCrest Capital Management's LH Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Labcorp (LH) in Q4 2022, closing a stake of 20,407 shares — an estimated $3.59M sold.

AlphaCrest Capital Management first reported a position in LH in Q4 2018 and held it in 14 quarters. The position peaked at $4.27M in Q2 2021. 970 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Labcorp position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 20,407 Labcorp shares in Q4 2022, an estimated $3.59M.
  • AlphaCrest Capital Management first reported a position in Labcorp in Q4 2018 and held it in 14 quarters.
  • AlphaCrest Capital Management's Labcorp position peaked at $4.27M in Q2 2021.
  • 970 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.